RESUMO
Transfusion of blood products in orthotopic liver transplantation (OLT) significantly increases post-transplant morbidity and mortality and is associated with reduced graft survival. Based on these results, an active effort to prevent and minimize blood transfusion is required. Patient blood management is a revolutionary approach defined as a patient-centered, systematic, evidence-based approach to improve patient outcomes by managing and preserving a patient's own blood while promoting patient safety and empowerment. This approach is based on three pillars of treatment: (1) detecting and correcting anemia and thrombocytopenia, (2) minimizing iatrogenic blood loss, detecting, and correcting coagulopathy, and (3) harnessing and increasing anemia tolerance. This review emphasizes the importance of the three-pillar nine-field matrix of patient blood management to improve patient outcomes in liver transplant recipients.
RESUMO
Introducción. Las transfusiones sanguíneas son un trasplante tisular con morbimortalidad y costos. Metodología. Se describen estrategias acordes a la literatura vigente con una revisión narrativa de los últimos diez años.Resultados y Conclusiones. Nos enfrentamos a pacientes añosos, con comorbilidades y para procedimientos complejos. Se deben racionalizar las transfusiones, protocolizando técnicas, mejorando las condiciones del paciente, disminuyendo las pérdidas sanguíneas operatorias, recuperando la sangre perdida y estableciendo la autodonación con un programa institucional.
Introduction. Blood transfusions are tissue transplants with morbimortality and costs involved. Methodology. A description of the strategies consistent with the current literature that offers a review of de last decade. Results and Conclusions. We have to deal with elderly patients with comorbidities who will undergo complex procedures. Blood transfusions must be streamlined, thorugh the development of technical protocols, improving the patients condition, decreasing operative blood loss, recovering any blood losses and establishing an institutional program for autologous blood donation.